| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/29/2003 | US6599741 Modulating transcription of genes in vascular cells |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599738 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 07/29/2003 | US6599737 Adenoviral vectors with tandem fiber proteins |
| 07/29/2003 | US6599735 Apparatus for use in the culturing of cells and generation of heterologous proteins |
| 07/29/2003 | US6599731 Proteases from gram positive organisms |
| 07/29/2003 | US6599730 Subtilisin for use in cleaning hard surfaces |
| 07/29/2003 | US6599729 Agarase for use in the generation of preferential oligiosaccharide derivatives |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599725 Polypeptide compositions for controlling cell death and disease resistance in plants |
| 07/29/2003 | US6599722 Method for producing ascorbic acid intermediates |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599718 Growth hormone secretagogue related receptors and nucleic acids |
| 07/29/2003 | US6599717 Polypeptide for use in the treatment tumors, diabetic retinopathy and rheumatoid arthritis |
| 07/29/2003 | US6599716 Nucleic acids encoding NTR3, a member of the TNF-receptor supergene family |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599705 Regulation of fungal gene expression |
| 07/29/2003 | US6599700 Methods for detection of transition single-nucleotide polymorphisms |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599697 Generation of phagemid library; provide genes coding antibodies, incubate with recombinase, recover vectors |
| 07/29/2003 | US6599695 Method for assaying for early gene expression in neuroblasts |
| 07/29/2003 | US6599692 Functional genomics using zinc finger proteins |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599504 Strain of bacteria of the species Lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
| 07/29/2003 | US6599502 Intracellular delivery vehicles |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599495 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/29/2003 | CA2269502C Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2179014C Method for inducing dna synthesis in neurons |
| 07/29/2003 | CA2146965C Cyclin complex rearrangement and uses related thereto |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2122044C Hiv immunotherapeutics |
| 07/29/2003 | CA2097931C Salmonella vaccines |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2082802C Method for expressing polypeptides in cyanobacteria |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2067136C Growth hormone antagonists |
| 07/29/2003 | CA2017157C Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/29/2003 | CA1341435C Recombinant pox virus for immunization against tumor-associated antigens |
| 07/25/2003 | CA2425623A1 Promoter promoting expression of a foreign gene in root and shoot apex |
| 07/24/2003 | WO2003060656A2 Simulation of gene expression control using connectrons. |
| 07/24/2003 | WO2003060655A2 INTERACTIONS OF CONNECTRONS, INTERFERENCE RNAs AND SMALL TEMPORAL RNAs IN PROKARYOTIC, ARCHEA AND EUKARYOTIC GENOMES |
| 07/24/2003 | WO2003060525A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060516A1 Screening method |
| 07/24/2003 | WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | WO2003060162A1 Method of specifying snp |
| 07/24/2003 | WO2003060160A2 Verification of fish origin based on nucleic acid pattern recognition |
| 07/24/2003 | WO2003060152A2 Alteration of restriction endonuclease specificity by genetic selection |
| 07/24/2003 | WO2003060151A2 Novel calpastatin (cast) alleles |
| 07/24/2003 | WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | WO2003060144A2 High fidelity dna polymerase compositions and uses therefor |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060141A1 Manufacturing method of recombinant protein in yeast by the use of secretory type vector |
| 07/24/2003 | WO2003060138A1 In increasing gene transfer efficiency by pre-incubation with endothelial cells |
| 07/24/2003 | WO2003060137A1 Method for recombinating plastid using procaryotic recombinase gene |
| 07/24/2003 | WO2003060136A2 D-galacturonate reductase of fragaria ananassa and its use in methods for increasing production of vitamin c in plants |
| 07/24/2003 | WO2003060135A2 Use of a wdv promoter for phloem-specific expression |
| 07/24/2003 | WO2003060134A1 Herbicide mode of action determination |
| 07/24/2003 | WO2003060133A2 Selective plant growth using d-amino acids |
| 07/24/2003 | WO2003060132A1 Novel phospholipase a2 and gene thereof |
| 07/24/2003 | WO2003060131A1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT |
| 07/24/2003 | WO2003060130A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | WO2003060128A2 Compositions, methods and systems for discovery of lipopeptides |
| 07/24/2003 | WO2003060127A2 Genes and proteins involved in the biosynthesis of lipopeptides |
| 07/24/2003 | WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 07/24/2003 | WO2003060125A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 07/24/2003 | WO2003060124A1 NOVEL PROTEINS PARTICIPATING IN STRESS RESPONSE VIA THE ACTIVATION OF p38 MAPK AND GENES THEREOF |
| 07/24/2003 | WO2003060123A1 Compositions and methods for identifying transformed cells |
| 07/24/2003 | WO2003060120A2 Means for identifying neisseiria menengitidis specific genes |
| 07/24/2003 | WO2003060119A2 Method for the quantification of in vivo nucleic acid levels |
| 07/24/2003 | WO2003060118A1 Iron-sulfur protein, protein-fad complex, electron transporter and method of measuring the inhibition of ferredotoxin activity |
| 07/24/2003 | WO2003060117A1 Method of monitoring gene expression |
| 07/24/2003 | WO2003060115A1 System for housing/processing carrier and method for housing/processing carrier |
| 07/24/2003 | WO2003060109A2 Human subtilisin/kexin-like convertase |
| 07/24/2003 | WO2003060106A1 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 07/24/2003 | WO2003060105A1 Defective entities and uses therefor |
| 07/24/2003 | WO2003060103A2 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof |
| 07/24/2003 | WO2003060101A2 Gene delivery system and methods of use |
| 07/24/2003 | WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | WO2003060093A2 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS |
| 07/24/2003 | WO2003060092A2 Modified fatty acid hydroxylase protein and genes |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060087A2 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/24/2003 | WO2003060086A2 Napi type iib polypeptides and methods for making and using same |
| 07/24/2003 | WO2003060084A2 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 07/24/2003 | WO2003060083A2 Cloning b and t lymphocytes |
| 07/24/2003 | WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 07/24/2003 | WO2003060079A2 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |